APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.
APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.
APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.
APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.
The university was one of 114 institutions nationwide to receive the honor, and one of only three in Missouri.